Form 13-F position report

IDEAYA BIOSCIENCES INC

Reported by Redmile Group LLC

IDYA CUSIP 45166A102 Manager CIK 0001425738

Reported 759,516 shares, down 163,162 (17.7%) from the prior quarter.

Reported value -34.1%; share count -17.7% vs. the prior quarter.

Reduced
% of reported 13F value 1.61% This manager · Q2 2024
Shares 759,516 Quarter-end amount reported
Reported value $26,666,607 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 33298006
2024-03-31 40487111
2024-06-30 26666607
2024-09-30 21578832
2024-12-31 15916010
2025-03-31 8756748
2025-06-30 9091024
2025-09-30 20190283
2025-12-31 25651528
2026-03-31 17363618
2026-06-30 23860329

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for IDEAYA BIOSCIENCES INC held by Redmile Group LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 640,202 +119,085 (22.9%) 1.6% $23,860,329 2026-08-14
Q1 2026 Reduced 521,117 -220,900 (-29.8%) 1.15% $17,363,618 2026-05-15
Q4 2025 Unchanged 742,017 0 (0.0%) 1.89% $25,651,528 2026-02-17
Q3 2025 Added 742,017 +309,523 (71.6%) 1.96% $20,190,283 2025-11-14
Q2 2025 Reduced 432,494 -102,106 (-19.1%) 0.97% $9,091,024 2025-08-14
Q1 2025 Reduced 534,600 -84,700 (-13.7%) 0.83% $8,756,748 2025-05-15
Q4 2024 Reduced 619,300 -61,850 (-9.1%) 1.11% $15,916,010 2025-02-14
Q3 2024 Reduced 681,150 -78,366 (-10.3%) 1.27% $21,578,832 2024-11-14
Q2 2024 Reduced 759,516 -163,162 (-17.7%) 1.61% $26,666,607 2024-08-14
Q1 2024 Reduced 922,678 -13,185 (-1.4%) 1.49% $40,487,111 2024-05-15
Q4 2023 New 935,863 +935,863 (0.0%) 1.19% $33,298,006 2024-02-14

Who else reported the position

232 managers reported IDEAYA BIOSCIENCES INC for Q2 2024.

Managers reporting IDEAYA BIOSCIENCES INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 11,270,083 +1,114,829 0.03% $395,692,626 14 qtrs
BlackRock Inc Added 6,807,790 +842,377 < 0.01% $239,021,508 21 qtrs
FEDERATED HERMES INC Reduced 4,855,790 -288 0.4% $170,486,787 16 qtrs
VANGUARD GROUP INC Added 4,266,773 +111,016 < 0.01% $149,806,400 21 qtrs
JANUS HENDERSON GROUP PLC Added 4,076,020 +267,570 0.08% $143,104,277 12 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 3,743,741 -308,759 0.02% $131,444,000 15 qtrs
STATE STREET CORPORATION Reduced 2,874,296 -289,658 < 0.01% $100,916,533 17 qtrs
Boxer Capital LLC Unchanged 2,202,812 0 4.07% $77,340,729 21 qtrs
Capital Research Global Investors Added 2,164,551 +187,681 0.02% $75,997,386 5 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Reduced 2,097,113 -533,179 1.23% $73,629,637 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
759,516
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.